News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ChinaBio(R) LLC Release: Big Four Accounting Firms Face Six-Month Suspension In China


1/24/2014 9:15:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 23, 2014 -- A US judge ordered the Big Four accounting firms to suspend China operations for six months. The problem? A conflict between US and China legal systems. US regulators want to see working documents from audits of China companies that may involve fraud. In the US, the Securities and Exchange Commission has the right to see those documents, but in China, they are declared secret. The Big Four, operating under China rules, cannot provide them. The order affects China companies that are listed in the US. In life science, this means WuXi PharmaTech and Mindray Medical. More details....

Stock Symbols: (NYSE WX) (NYSE: MR)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES